Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases
Open Access
- 1 August 1999
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 13 (8), 979-995
- https://doi.org/10.1046/j.1365-2036.1999.00596.x
Abstract
Ursodeoxycholic acid (ursodiol) is a non‐toxic, hydrophilic bile acid used to treat predominantly cholestatic liver disorders. Better understanding of the cellular and molecular mechanisms of action ...Keywords
This publication has 164 references indexed in Scilit:
- Ursodeoxycholic Acid Enhances Glucocorticoid-Induced Tyrosine Aminotransferase-Gene Expression in Cultured Rat HepatocytesBiochemical and Biophysical Research Communications, 1997
- Ursodiol for Primary Sclerosing CholangitisNew England Journal of Medicine, 1997
- Efficacy of ursodeoxycholic acid therapy in chronic viral hepatitis C with high serum ?-glutamyltranspeptidase levelsThe Esophagus, 1996
- The role of mdr2 P-glycoprotein in biliary lipid secretion. Cross-talk between cancer research and biliary physiologyJournal of Hepatology, 1995
- Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosisDigestive Diseases and Sciences, 1993
- Ursodeoxycholic acid-dependent activation of the glucocorticoid receptorBiochemical and Biophysical Research Communications, 1992
- Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liverJournal of Hepatology, 1990
- Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-upDigestive Diseases and Sciences, 1985
- Ursodeoxycholic acid in the treatment of cholesterol cholelithiasisDigestive Diseases and Sciences, 1982
- Tauroursodeoxycholate prevents taurocholate induced cholestasisLife Sciences, 1982